Compound Detail
CHEMBL33238
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL33238 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MKHFHHLLYNWQHF-UHFFFAOYSA-N |
2
Targets
3
Activities
2
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
314.4
MW (Da)
4.42
ALogP
4
HBA
1
HBD
46.0
PSA (Ų)
0.85
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 6.22
IC50 1 meas. best 5.47
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MT4 CHEMBL388 | EC50 | 6.22 | 6.22 | 600.0 | 2 |
| Human immunodeficiency virus type 1 reverse transcriptase CHEMBL247 | IC50 | 5.47 | 5.47 | 3400.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MT4 | EC50 | = | 600.0 | nM | 6.22 | Dose required to achieve 50% protection of MT-4 cells from HIV-1 induced cytopat... | 7650679 |
| MT4 | EC50 | = | 600.0 | nM | 6.22 | Dose required to achieve 50% protection of MT-4 cells from the HIV-1 induced cyt... | 9154967 |
| Human immunodeficiency virus type 1 reverse transcriptase | IC50 | = | 3400.0 | nM | 5.47 | Dose required to inhibit HIV-1 recombinant reverse transcriptase (rRT) activity ... | 7650679 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 7650679 | 10.1021/jm00017a010 | MT4 | 3 |
| 9154967 | 10.1021/jm960802y | MT4 | 2 |
| 7650679 | 10.1021/jm00017a010 | Human immunodeficiency virus type 1 reverse transcriptase | 1 |
| 9154967 | 10.1021/jm960802y | Glutathione S-transferase Mu 1 | 1 |
Data from ChEMBL 36 via Core Engine